Sinopharm Group Co. Ltd. is a pharmaceutical distribution and manufacturing company established in 2003. The group operates a full supply chain ecosystem centered on the distribution of drugs and medical devices, extending into pharmaceutical manufacturing, chemical reagents, medical services, and industrial-finance integration. Its business segments include drug distribution, device distribution, and the operation of retail pharmacy networks under the Guoda Pharmacy and SPS+ brands. The company serves hospitals, pharmacies, and other healthcare institutions across China, leveraging a nationwide distribution network and logistics infrastructure. Notable subsidiaries include Sinopharm Shares, Sinopharm Yizhi, Sinopharm Xingsha, and Sinopharm Digital Technology. The company maintains strategic partnerships with major pharmaceutical manufacturers such as Pfizer, Merck, AstraZeneca, Hengrui Medicine, and Innovent Biologics to facilitate the commercialization and distribution of their products.

Summarised from the company's own disclosures, fiscal year ended Apr 2026

Industry Medical Distribution Homepage sinopharmgroup.com.cn
Sector Healthcare IR page ir.sinopharmgroup.com.cn/html/index.php
Tags
drug distribution, medical device distribution, pharmaceutical manufacturing, retail pharmacy, chemical reagents, medical services, supply chain management, logistics, Guoda Pharmacy, SPS+, Sinopharm Shares, Sinopharm Yizhi, Sinopharm Xingsha, Sinopharm Digital Technology, Sinopharm Southwest, Sinopharm Sichuan, Sinopharm Modern
Press page —

Metrics

Valuation  
Market cap HK$ 52.987B
Market cap (USD) $ 6.753B
P/E 6.60
PEG —
P/BV 0.33
P/S 0.08
P/OCF 1.84
P/FCF —
Dividend yield 4.7%
Turnover / mcap 0.10%
Returns  
ROE 5.5%
ROI 5.2%
ROIC 11.6%
Profit margin 1.2%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -5.7%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 57.0%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 5.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 575.168B 584.508B 596.57B 552.148B 521.051B 456.415B 425.273B 344.526B 277.717B 258.388B 227.069B 200.131B 166.866B 135.787B 102.225B 69.234B
Net profit 7.155B 7.05B 9.054B 8.526B 7.759B 7.187B 6.253B 5.836B 5.283B 4.647B 3.761B 2.875B 2.25B 1.974B 1.561B 1.209B

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 18.74 19.16 18.98 17.94 17.97 16.11 25.35 28.71 26.51 — — — — — — —
Price performance 12m 0 0.02 -0 -0.05 0.2 -0.36 -0.15 0.07 — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Sinopharm Group Co. Ltd. (ticker 1099), listed in Hong Kong.

ETFs Holding Sinopharm Group Co. Ltd.

ETF Weight in ETF Shares Market value As of
AVES 0.19% 1,262,400 $ 2.728M Nov 16, 2026
DFSE 0.11% 307,600 $ 656.399K Nov 12, 2026
AVEM 0.08% 10,106,800 $ 21.84M Nov 16, 2026
AVSE 0.06% 62,400 $ 134.84K Nov 16, 2026
DFEV 0.05% 566,400 $ 1.209M Nov 12, 2026
DFEM 0.05% 2,129,600 $ 4.544M Nov 12, 2026
DFAE 0.03% 1,391,600 $ 2.97M Nov 12, 2026
DFAX 0.02% 884,000 $ 1.886M Nov 12, 2026